David E. Sterner

4.5k total citations · 1 hit paper
32 papers, 3.5k citations indexed

About

David E. Sterner is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, David E. Sterner has authored 32 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in David E. Sterner's work include Ubiquitin and proteasome pathways (13 papers), Genomics and Chromatin Dynamics (12 papers) and Fungal and yeast genetics research (10 papers). David E. Sterner is often cited by papers focused on Ubiquitin and proteasome pathways (13 papers), Genomics and Chromatin Dynamics (12 papers) and Fungal and yeast genetics research (10 papers). David E. Sterner collaborates with scholars based in United States, France and Bulgaria. David E. Sterner's co-authors include Shelley L. Berger, Rimma Belotserkovskaya, Jerry L. Workman, Laura J. Duggan, Patrick A. Grant, Arno L. Greenleaf, Michael R. Mattern, Fred Winston, Tauseef R. Butt and Jae Moon Lee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Genes & Development.

In The Last Decade

David E. Sterner

31 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acetylation of Histones and Transcription-Related Factors

2000 1.4k citations David E. Sterner, Shelley L. Berger profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David E. Sterner United States	21	3.1k	483	334	291	230	32	3.5k
Alain Verreault Canada	36	5.3k 1.7×	573 1.2×	787 2.4×	331 1.1×	170 0.7×	64	5.8k
Gerald Brosch Austria	42	3.5k 1.2×	632 1.3×	711 2.1×	192 0.7×	102 0.4×	72	4.2k
Anton Eberharter Germany	22	2.8k 0.9×	195 0.4×	505 1.5×	273 0.9×	192 0.8×	31	3.2k
Philip R. Gafken United States	29	2.7k 0.9×	257 0.5×	219 0.7×	252 0.9×	242 1.1×	50	3.4k
Dieter Kressler Switzerland	34	3.7k 1.2×	520 1.1×	213 0.6×	295 1.0×	113 0.5×	63	4.1k
Helen R. Flynn United Kingdom	27	2.4k 0.8×	602 1.2×	310 0.9×	250 0.9×	267 1.2×	49	3.1k
James E. Brownell United States	21	5.1k 1.7×	875 1.8×	547 1.6×	436 1.5×	291 1.3×	34	5.7k
Jae Hong Seol South Korea	28	2.5k 0.8×	453 0.9×	356 1.1×	299 1.0×	314 1.4×	53	3.0k
Sharon Y. Roth United States	28	5.6k 1.8×	481 1.0×	742 2.2×	567 1.9×	334 1.5×	39	6.1k
Peter J. Watson United Kingdom	20	1.8k 0.6×	367 0.8×	159 0.5×	260 0.9×	104 0.5×	25	2.2k

Countries citing papers authored by David E. Sterner

Since Specialization

Citations

This map shows the geographic impact of David E. Sterner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Sterner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Sterner more than expected).

Fields of papers citing papers by David E. Sterner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Sterner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Sterner. The network helps show where David E. Sterner may publish in the future.

Co-authorship network of co-authors of David E. Sterner

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Sterner. A scholar is included among the top collaborators of David E. Sterner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Sterner. David E. Sterner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sterner, David E., et al.. (2025). Unraveling chain specific ubiquitination in cells using tandem ubiquitin binding entities. Scientific Reports. 15(1). 22961–22961.

Huang, Chengqun, Jon Sin, David E. Sterner, et al.. (2024). Enhanced Parkin-mediated mitophagy mitigates adverse left ventricular remodelling after myocardial infarction: role of PR-364. European Heart Journal. 46(4). 380–393. 12 indexed citations

Sterner, David E., et al.. (2022). A Method to Monitor Activity of SARS-CoV-2 Nsp3 from Cells. Methods in molecular biology. 2591. 269–282. 2 indexed citations

Abro, Asma, Rayyan Azam Khan, Asad Ur Rehman, et al.. (2021). Combined deep learning and molecular docking simulations approach identifies potentially effective FDA approved drugs for repurposing against SARS-CoV-2. Computers in Biology and Medicine. 141. 105049–105049. 29 indexed citations

Kumar, Suresh, Mariko Okumura, David E. Sterner, et al.. (2019). TAM receptors attenuate murine NK‐cell responses via E3 ubiquitin ligase Cbl‐b. European Journal of Immunology. 50(1). 48–55. 27 indexed citations

Wang, Liqing, Suresh Kumar, Satinder Dahiya, et al.. (2016). Ubiquitin-specific Protease-7 Inhibition Impairs Tip60-dependent Foxp3 + T-regulatory Cell Function and Promotes Antitumor Immunity. EBioMedicine. 13. 99–112. 91 indexed citations

Hughes, Stephen R., Sookie S. Bang, Badal C. Saha, et al.. (2015). Process for Assembly and Transformation into Saccharomyces cerevisiae of a Synthetic Yeast Artificial Chromosome Containing a Multigene Cassette to Express Enzymes That Enhance Xylose Utilization Designed for an Automated Platform. SLAS TECHNOLOGY. 20(6). 621–635. 7 indexed citations

Nicholson, Benjamin, Suresh Kumar, Saket Agarwal, et al.. (2014). Discovery of Therapeutic Deubiquitylase Effector Molecules: Current Perspectives. SLAS DISCOVERY. 19(7). 989–999. 10 indexed citations

Marblestone, Jeffrey G., et al.. (2013). Comprehensive Ubiquitin E2 Profiling of Ten Ubiquitin E3 Ligases. Cell Biochemistry and Biophysics. 67(1). 161–167. 22 indexed citations

10.

Mallory, Michael J., et al.. (2012). Gcn5p-dependent acetylation induces degradation of the meiotic transcriptional repressor Ume6p. Molecular Biology of the Cell. 23(9). 1609–1617. 20 indexed citations

11.

Hughes, Stephen R., David E. Sterner, Kenneth M. Bischoff, et al.. (2008). Engineered Saccharomyces cerevisiae strain for improved xylose utilization with a three-plasmid SUMO yeast expression system. Plasmid. 61(1). 22–38. 19 indexed citations

12.

Nicholson, Benjamin, Craig A. Leach, Seth J. Goldenberg, et al.. (2008). Characterization of ubiquitin and ubiquitin‐like‐protein isopeptidase activities. Protein Science. 17(6). 1035–1043. 115 indexed citations

13.

Ingvarsdottir, Kristin, David E. Sterner, Milos Dokmanovic, et al.. (2006). Histone sumoylation is a negative regulator in Saccharomyces cerevisiae and shows dynamic interplay with positive-acting histone modifications. Genes & Development. 20(8). 966–976. 234 indexed citations

14.

Arnold, Jamie J., Alejandro Bernal, Uzodinma Uche, et al.. (2005). Small ubiquitin-like modifying protein isopeptidase assay based on poliovirus RNA polymerase activity. Analytical Biochemistry. 350(2). 214–221. 24 indexed citations

15.

Zuo, X, Michael R. Mattern, David E. Sterner, et al.. (2005). Expression and purification of SARS coronavirus proteins using SUMO-fusions. Protein Expression and Purification. 42(1). 100–110. 68 indexed citations

16.

Sterner, David E., et al.. (2002). The SANT Domain of Ada2 Is Required for Normal Acetylation of Histones by the Yeast SAGA Complex. Journal of Biological Chemistry. 277(10). 8178–8186. 99 indexed citations

17.

Eberharter, Anton, David E. Sterner, David Schieltz, et al.. (1999). The ADA Complex Is a Distinct Histone Acetyltransferase Complex in Saccharomyces cerevisiae. Molecular and Cellular Biology. 19(10). 6621–6631. 154 indexed citations

18.

Grant, Patrick A., David E. Sterner, Laura J. Duggan, Jerry L. Workman, & Shelley L. Berger. (1998). The SAGA unfolds: convergence of transcription regulators in chromatin-modifying complexes. Trends in Cell Biology. 8(5). 193–197. 147 indexed citations

19.

Morris, Daniel P., et al.. (1997). Assaying CTD Kinasesin Vitroand Phosphorylation-Modulated Properties of RNA Polymerase IIin Vivo. Methods. 12(3). 264–275. 19 indexed citations

20.

Sterner, David E., Jae Moon Lee, S. E. Hardin, & Arno L. Greenleaf. (1995). The Yeast Carboxyl-Terminal Repeat Domain Kinase CTDK-I Is a Divergent Cyclin–Cyclin-Dependent Kinase Complex. Molecular and Cellular Biology. 15(10). 5716–5724. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact